Vimta Labs Incorporates US Subsidiary

Vimta Labs Limited has announced the incorporation of its wholly-owned subsidiary in the United States of America (USA), named Vimta Labs LLC. This strategic move, approved by the Board of Directors on October 30, 2026, aims to support the parent company's core business lines, including preclinical studies, clinical trials, and analytical testing for the pharmaceutical and biologics sectors. The incorporation was completed on September 24, 2026, with 100% of the initial paid-up capital subscribed in cash. This expansion into the US market is expected to bolster Vimta Labs' global presence and service offerings in the contract research and testing organization (CRO/CRTO) space.